agºÍ¼Ç

À´Ô´£ºÑ§ÀúÍøÕ¾  £¬×÷Õߣº   £¬£º

°¥à£  £¬²»ÖªµÀÄãÊDz»ÊǸúÎÒÒ»Ñù  £¬³öÈ¥Íæ×îϲ»¶×êСÏï×Ó £¿¸ü×ÓÊÇÄÇÖÖ¿í¿í´ó´óµÄÖ÷¸ÉµÀ  £¬Ã»É¶Î¶µÀ  £¬¸ãÂÑûÒâ˼¡£Ð¡Ïï×Ó²ÅÊDzØ×źù¤¾ßµÄµØ·½  £¬ÓÈÆäÊÇÁÙÒÊ»ð³Ã÷ÈÕ¾ËÄÖÜ  £¬à£à£µØ  £¬³ÔºÈÍæÀÖÒ»ÌõÁú  £¬¾ø¶ÔÈÃÄãˬµ½ÂѶ¼µø£¡½ñÌìÎҾʹøÄã×ß×ßÁÙÒÊ»ð³Ã÷ÈÕ¾ËÄÖܵÄСÏï×Ó  £¬°ü¹ÜÄã²»À˲ÙÐÄÇé¡£

СÏï×ÓÀï  £¬³ÔºÈ²ÅÊÇÕý×ڵĽ²¾¿

¸úÄ㽲࣠ £¬ÁÙÒÊ»ð³Ã÷ÈÕ¾ËÄÖܵÄСÏï×ÓÀï  £¬ÂѺóԵŤ¾ß¶àµÃºÜ  £¬¼òÖ±¾ÍÊdzԻõÌìÌá£ÓиãµÄÔç²Í̯  £¬¶¹¸¯ÄÔ¡¢ÓÍÌõ  £¬ÂÑÏã £»ÁíÓÐÄÇÖÖС¹Ý×Ó  £¬Âô×ÅËíµÀµÄɽ¶«¼å±ý¾í´ó´Ð¡£±ð¿´Çé¿öÆßºÚ°ËºÚ  £¬Î¶µÀµð¸ÜµÃºÜ¡£ÎÒ¹À¶ÑÄã³ÔÒ»¿Ú  £¬ÂѶ¼Ï뺰³öÀ´  £¬»¹Òª¼Ó¸ö¼¦µ° £¿Ã»ÂÑÀí  £¬±ØÐëÀ´Ò»¸ö£¡

à£à£µØ  £¬ÁíÓÐÄÇÖÖ±ÈâÆÌ  £¬ÃſڹÒ×ÅÒ»ÅÅÅÅÓÍÁÁÁÁµÄÖíÍ·Èâ¡¢ÖíÌã×Ó  £¬ÂÑ»ðÌÌ¡£ÄãÒÑÍùÎÊÀϰåÄÃÒ»¿é  £¬ÂÑÊǵÄ  £¬ÄÇÖÖÏãζֱ½Ó³å±Ç×ÓÀï  £¬¸ãµÃÄãÂѶ¼ñ²ÁË¡£¼ÇµÃภ £¬ÂòµÄʱºò¸úÀϰ彲  £¬¡°Àϰå  £¬¸øÎÒÇÐÂÑÏãµãµÄ£¡¡± ÌýÎÒȰ  £¬±ð¸ãŨˮ  £¬Çкñµã  £¬ÂÑÏãࣣ¡

¹äСÏï×Ó  £¬ÄÜÕÒµ½×ÔÖÆÓÖÓиãµÄ»õ

ÁÙÒÊ»ð³Ã÷ÈÕ¾ËÄÖܵÄСÏï×Ó²»¿ÉÊdzԺȺà  £¬Âò¹¤¾ßÒ²Óиã¡£Ò·þ¡¢Ð¬×Ó¡¢ÔÓ»õ  £¬É¶¶¼ÓС£ÄãÈç¹ûÊǸöÐÑéÏé­  £¬ÌÔµã×ÔÖÆ»õ  £¬È¥ÄÇЩС̯ÆÌ¾Í¶ÔÁË¡£ÓеÄ̯Ö÷ÊÇÀÏÁÙÒÊÈË  £¬¼Û¸ñ½²µÃÂÑʵÔÚ  £¬ÕæÊÇû»°½²¡£Äã¸úËû³¶Á½¾ä  £¬Ã»×¼»¹ÄÜ´ò¸öÕÛ¡£

²»¹ý࣠ £¬Âò¹¤¾ßÒªÓеãÑÛÁ¦¾¢  £¬±ð±»ÄÇЩ½ÐÄñºöÓÆÁË¡£ÓÐЩ̯×ÓÊÇרÃÅ¿ÓÍâµØÈ˵Ä  £¬¹¤¾ß¿´×ÅÔÃÄ¿µÄ  £¬½á¹ûÄûØÈ¥Ã»ÂÑÓ᣼Ç×Å  £¬»õ±ÈÈý¼Ò  £¬ÃþÃþÁÏ×Ó  £¬¿´¿´×ö¹¤  £¬±ð¸ãµÃ×Ô¼ºÏñ¸öÃÆÍ·¼¦  £¬×îºóµôÄ㹫¹ê¡£

Ïà¹ØÍ¼Æ¬

²ØÔÚÏï×ÓÀïµÄÀÏζµÀ  £¬Õ¦ÕÒ £¿

Äã¿ÉÄÜ»áÎÊ࣠ £¬ÁÙÒÊ»ð³Ã÷ÈÕ¾ËÄÖÜСÏï×ÓÄÇô¶à  £¬Õ¦ÖªµÀÄÄÌõÏï×ÓÖµµÃ¹ä £¿à¸  £¬¸úÄ㽲࣠ £¬×î¼òµ¥µÄÒªÁì¾ÍÊÇ¿´ÈËÆø  £¬ÄÄ¿­È˶à  £¬¾ÍÍùÄÄ¿­¿Ë¡ £ÁíÓÐÒ»¸öÐÑÁúµÄ²½·¥¡ª¡ªÎÅζµÀ¡£Ð¡Ïï×ÓÀï¼å³´ÅëÕ¨µÄζµÀ  £¬ÂÑÏãµÄ  £¬Ã»ÐÅÄã¿ËÊÔÏÂ×Ó  £¬¿Ï¶¨´í²»ÁË£¡

ÐÑÁúµã£º×îÈÈÄÖµÄÏï×ÓÔÚ»ð³Ã÷ÈÕ¾¶«±ßÄÇ¿é  £¬ÍùÏÂÔÙ¹ÕÁ½ÌõÏï×Ó  £¬ÂѶàºÃ³ÔµÄ  £¬¼ÇµÃ¼°Ôç  £¬ÍíÁËÁ¬µØ·½¶¼Ã»µÃ×øà££¡
Ïà¹ØÍ¼Æ¬

×ܽ᣺СÏï×Ó²ÅÊǶ¼»áÁé»ê

½²µ½ÕâÀïÄãÏþµÃÁ衃 £¿ÁÙÒÊ»ð³Ã÷ÈÕ¾ËÄÖÜСÏï×Ó  £¬¾ø¶ÔÊdzԺÈÍæÀֵĺÃÈ¥´¦¡£±ð¸ãÂÑû¼û  £¬Ã»ÐÅÄã¿ËÊÔÏÂ×Ó  £¬°üÄ㲻ʧÍû¡£Ð¡Ïï×ÓÓÐζµÀ¡¢ÓйÊÊ  £¬ÄÄÅÂËæ±ã×ß×ß  £¬¶¼»áÈÃÄãÓз¢Ã÷¡£ÁÙÒʵÄËíµÀ·çÇé  £¬È«ÔÚÕâЩ²»ÆðÑÛµÄСµØ·½Àï²Ø×Å  £¬¶®ÂÑû £¿


ÄǾ¿¾¹Òª¸ü×ÓÑ¡²Åû²È¿Ó £¿ÂѼòµ¥£¡Äã¾Í¼Ç×ÅÒ»µã£ºÈËÆø¾Û¼¯µÄµØ·½  £¬×¼Ã»´í£¡¿´ÄÄ¿­È˶à  £¬Ëæ×Å×ß  £¬×¼Óи㣡

ÁÙÒÊ»ð³Ã÷ÈÕ¾, СÏï×Ó, ɽ¶«ÃÀʳ, ËíµÀ·çÇé, С̯¾­¼Ã

¡¶³¤°²Ïü±ßÌØÊâЧÀÍ¡·

¶øÎ÷²¿Ö¤È¯Í¶ÐÐÒµÎñÊÕÈëÔö³¤Ö÷ÒªÀ´Ô´ÓÚծȯ¿¯ÐÐÁ¿µÄÉÏÉý¡£2025ÄêÉϰëÄê  £¬Î÷²¿Ö¤È¯¿¯Ðй«Ë¾Õ®È¯93Ö»  £¬Í¬±ÈÔö³¤116.28%  £¬¹«Ë¾³ÐÏú¹æÄ£394.82ÒÚÔª  £¬Í¬±ÈÔö³¤80.09%¡£

¡¶51Æ·²è²è�¶ùÂÛ̳¡·

ԼĪһСʱºó  £¬³ÂÃÏʵÑé¿¿½ü±¬Õ¨³§Çø  £¬Â·ÉÏ¿´µ½´ó×Ú¾¯²ìºÍÏû·ÀÈËÔ±  £¬³§ÇøÖÜΧÒÑÉèÖÃΧµ²  £¬·â±ÕÁËÏÖ³¡¡£

¡¶¹ðÁÖÆ·²èÂÛ̳¡·

È«ÇòÁìÏȵÄÌõÔ¼Ñо¿¡¢¿ª·¢ºÍÉú²ú£¨CRDMO£©Ð§À͹«Ë¾Ò©Ã÷ÉúÎWuXi Biologics, 2269.HK£©ÓëÖÂÁ¦ÓÚ¿ª·¢ÏÂÒ»´úÃâÒßÁÆ·¨µÄÈ«ÇòÁÙ´²½×¶ÎÉúÎï¼¼Êõ¹«Ë¾ºº¿µÉú¼¼£¨TPEx£º7827£©ÅäºÏÐû²¼  £¬Ë«·½Ç©ÊðÕ½ÂÔÏàÖúЭÒé  £¬Ò©Ã÷ÉúÎォΪºº¿µÉú¼¼¹ÜÏßÖжà¿îÐÂÒ»´úË«¹¦Ð§¼°¶à¹¦Ð§ÈÚºÏÂѰ×ÏîÄ¿Ìṩ¿ª·¢ÓëÉú²úЧÀÍ¡£

ÍøÕ¾µØÍ¼